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Abstract 
Objective: This study aimed to determine the effects of Phaleria macrocarpa’s extract on TNF-α and LC3-II level 
and their correlation in preeclampsia-induced HUVEC. 
Methods: This study used HUVEC culture as an in vitro model and Phaleria macrocarpa’s extract, widely used as 
an anti-inflammation and antioxidant.
Results: Phaleria macrocarpa’s extract reduce TNF-α level siginificantly at concentration of 7.813μg/mL and at 
62.5μg/mL reduce TNF-α level to normal level. There was no significant decrease and  reduction to normal level 
in LC3-II. TNF-α has a strong positive correlation with LC3-II (r=0.958), that reduced TNF-α level will decrease 
LC3-II levels, where a decrease in TNF-α level of 1pg/mL will reduce LC3-II levels by 0.413pg/mL.
Conclusion: Thus, Phaleria macrocarpa’s extract might be used to overcome endothelial dysfunction and 
autophagy in preeclampsia.
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Ekstrak Phaleria macrocarpa Menghambat Otofagi Melalui TNF-α Pada 
Kultur Sel HUVEC
Abstrak: 
Tujuan: Penelitian ini bertujuan untuk mengetahui efek ekstrak Phaleria macrocarpa pada inflamasi dan otofagi 
pada sel endotel dengan mengukur kadar TNF-α dan LC3-II pada HUVEC yang diinduksi serum preeklampsia.
Metode: Penelitian ini menggunakan kultur HUVEC sebagai model in-vitro yang banyak digunakan untuk 
memelajari patogenesis preeklampsia. Phaleria macrocarpa (Scheff.) Boerl juga dikenal sebagai Mahkota Dewa 
secara luas digunakan sebagai anti-inflamasi dan antioksidan 
Hasil: Hasil menunjukkan ekstrak Phaleria macrocarpa menurunkan kadar TNF-α secara signifikan pada 
konsentrasi 7.813 μg/mL dan konsentrasi 62.5 μg/mL menurunkan kadar TNF-α ke kadar normal. Tidak terdapat 
penurunan signifikan rerata kadar LC3-II antara kontrol dan model PE dan dibutuhkan ekstrak Phaleria macrocarpa 
pada konsentrasi lebih dari 250 μg/mL untuk menurunkan kadar LC3-II pada model preeklamsia ke kadar hamil 
normal. Kadar TNF-α memiliki korelasi positif yang bermakna dengan LC3-II dengan tingkat korelasi sangat kuat 
(r = 0.847), dimana penurunan kadar TNF-α sebesar 1 pg/mL akan menurunkan kadar LC3-II sebesar 0.413 pg/
mL.
Kesimpulan: Dengan demikian, ekstrak Phaleria macrocarpa dapat digunakan untuk mengatasi disfungsi endotel 
dan otofagi pada preeklampsia.
Kata kunci: Phaleria Macrocarpa, Preeklampsia, HUVEC, TNF-α, LC3-II
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Introduction
Preeclampsia is one of the leading causes of 
maternal morbidity and mortality worldwide. 
It is estimated that maternal deaths worldwide 
are around 500,000 annually and about 
10%−15% are due to preeclampsia and 
eclampsia.1 In 2006 WHO reported that 16% 
of maternal deaths in developed countries 
due to hypertension in pregnancy, higher than 
due to bleeding of 13%, abortion of 8% and 
sepsis of 2%.2 
Although there have been many studies 
but the etiopathogenesis of preeclampsia is 
still not fully elucidated but it is believed to 
be a multifactors. Thus preeclampsia is called 
the ‘disease of theories’.3 
Endothelial dysfunction plays an 
important role in the pathophysiology of 
preeclampsia. Under normal circumstances, 
endothelial cells maintain vascular integrity, 
regulating blood pressure, preventing 
intravascular coagulation, and regulating 
vascular smooth muscle tone by producing 
various substances including nitric oxide 
(NO), endothelin, prostacyclin and 
thromboxane.4 Endothelial dysfunction 
occurs due to cytotoxic factors in the 
circulation such as superoxide anions (O2) and 
H2O2, trophoblast debris, pro-inflammatory 
cytokines, metabolic factors, and anti-
angiogenic factors produced by oxidative 
stressed placenta and causing excessive 
maternal inflammatory responses.5
Tumor Necrosis Factor-α (TNF-α) is 
considered as one of the potentially specific 
markers for preeclampsia. In endothelial 
cells TNF-α causes endothelial dysfunction 
by increasing oxidation of low-density 
lipoprotein (LDL), inhibiting eNOS enzymes 
causing NO levels decrease and increasing 
free radical production by xanthine oxidase 
enzyme, then binds to endothelial cells and 
produces an O2
- anion in endothelial cells.6-7 
TNF-α levels in preeclampsia placenta 
were significantly higher than normal 
pregnancies with ELISA method and 
allegedly TNF-α increases oxidative stress by 
stimulating the formation of ROS.3
Udenze et al.8 found that TNF-α level in 
preeclampsia serum is significantly higher 
than in the serum of normal pregnancies 
(44.80 pg/mL vs 8.15 pg/mL).
Autophagy plays an important role in the 
pathophysiology of preeclampsia as observed 
in the failure of trophoblast invasion and 
spiral artery remodeling. Autophagy acts to 
increase extravillous trophoblast invasion 
and increase the remodeling of the spiral 
arteries under normal physiological hypoxia 
occurring early in pregnancy.9-10  Autophagy 
can be induced by many overlapping factors 
such as nutritional deficiencies, growth 
factors deficiencies, and intracellular stress 
due to hypoxia.11-13
Autophagy-related proteins (ATG) 
such as Beclin-1 and LC3-II are some 
of the autophagy markers.12-14 Strong 
evidence that autophagy has occurred is the 
formation of vesicles in the cytoplasm called 
autophagosomes. LC3-II is indispensable in 
the final stages of autophagosome formation 
so that it is used as a typical marker of 
autophagosome formation.14-15 Oh et al.11 
found that the administration of TNF-α 
in trophoblast cell line cultures causes an 
increase in expression of LC3-II. TNF-α 
is thought to stimulate autophagy through 
mechanisms that depend on ROS.16 thus 
it is believed that the autophagy process 
will be inhibited if oxidative stress and the 
inflammatory process are inhibited.
Preeclampsia treatment will only 
be successful and rational if based on 
understanding the disease pathophysiology. In 
an attempt to determine the pathophysiology 
of a disease, in vitro model research is 
considered the best and most effective way.17
HUVEC (Human Umbilical Vein 
Endothelial Cell) cell line culture and 
trophoblast cell line is an in vitro model 
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widely used to study the pathogenesis of 
preeclampsia.
Herbs or medicinal plants have been used 
traditionally as alternative medicine since 
ancient times. Phaleria macrocarpa (Scheff.) 
Boerl also known as Mahkota dewa belongs to 
the Thymelaceae family, that originated from 
Papua province, is very popular in Indonesia 
used in the treatment of various diseases such 
as cancer, hemorrhoids, diabetes mellitus, 
hypertension, and others. 18-20 The phenol 
and flavonoid compounds in the extract of 
Phaleria macrocarpa have high antioxidant 
and anti-inflammatory activity. 20-21
The aim of this study is to determine 
the effects of Phaleria macrocarpa (Scheff.) 
Boerl Extract on Tumor Necrosis Factor 
– Alpha (TNF- α) and LC3-II Level In 
preeclampsia-induced Human Umbilical 
Vein Endothelial Cell (HUVEC).
Method
Serum samples used were obtained from 
women at >20−42 weeks of gestational age, 
which were diagnosed preeclampsia at Dr. 
Hasan Sadikin General Hospital. Research 
subjects have fulfilled inclusion and exclusion 
criteria.
HUVEC cell line ATCC CRL-1730 
obtained from American Type Collection 
Culture. HUVEC cell line was growth into 
tissue culture flask (25 cm2) containing 
RPMI 1640 media, 20% (v/v) FBS qualified 
(fetal bovine serum) supplementation, 10% 
endothelial supplement, 1% Penicillin G - 
Streptomycin solution stabilized, and 1% 
antimycotic Fungizone Amphotericin B and 
1% gentamicin. The cells were then incubated 
at 37OC and 5% CO2 (v/v). Culture medium 
is replaced every 2−3 days. Then cells are 
passaged every seven days until reach 80-
90% confluence.
Phaleria macrocarpa (Scheff.) Boerl 
was obtained from the Research Institute 
for Industrial Plants at Manoko, Lembang, 
West Java, Indonesia. The plant species 
was identified by the laboratory of Plant 
Taxonomy staff at Herbarium Bogoriense, 
Bogor, Indonesia.
As many as 6x105 cells/mL induced 
with normal and preeclampsia serum, were 
placed into 60-well plate, then incubated 
at 37OC and 5% CO2 (v/v). Each well then 
was washed with 37OC PBS 3−4 times. 
Furthermore, various concentrations of 
Phaleria macrocarpa’s extract (0,977; 1,953; 
3,906; 7,813; 15,625; 31,25; 62,5; 125; and 
250 μg/mL) were added into each well, then 
incubated for 24 and 72 hours 37OC and 5% 
CO2 (v/v). Each well then was washed with 
37OC once for five minutes. Transfer the cells 
into centrifugation tube using 1.5 mL pipette. 
Centrifuged at 1.500 rpm for 10 minutes at 
4°C. Use the supernatant as a sample for the 
ELISA method measurement of TNF-α and 
LC3-II levels, then the rest of the sample can 
be stored at -80 °C. 
Data was analyzed with repeated 
ANOVA (analysis of variance) test which 
is followed by Bonferroni test as post hoc 
comparison test and Pearson correlation test 
and Linear regression to find correlation 
between the two variables.
Results
TNF-α levels in preeclampsia HUVEC 
culture model is higher than normal 
pregnancy HUVEC culture model. The 
TNF-α levels at 72 hours incubation time was 
lower than the 24 hours incubation time in 
both normal and preeclampsia models. LC3-
II levels in preeclampsia HUVEC culture 
model is higher than normal  pregnancy 
HUVEC culture model. The LC3-II levels at 
72 hours incubation time was higher than the 
24 hours incubation time in both normal and 
preeclampsia models.
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Table 1 TNF-α levels (pg/mL) in preeclampsia and normal serum-induced HUVEC culture 
model treated with Phaleria macrocarpa’s extract in various concentrations 
incubated for 24 and 72 hours.
Phaleria macrocarpa’s 
extract  concentration 
(μg/mL)
24 H INCUBATION TIME 72 H INCUBATION TIME
NP*
 (Mean ± SD)
PE 
(Mean ± SD)
NP* 
(Mean ± SD)
PE 
(Mean ± SD)
Control 8.7  ± 0.04 18.7 ± 0.00 7.8 ± 0.03 17.8 ± 0.03
0.977 8.2  ± 0.00 18.3 ± 0.05 7.4 ± 0.01 17.4 ± 0.00
1.953 7.9  ± 0.00 17.9 ± 0.00 6.9 ± 0.00 16.7 ± 0.01
3.906 7.4  ± 0.07 15.3 ± 0.08 6.3 ± 0.02 14.6 ± 0.31
7.813 6.8  ± 0.00 14.5 ± 0.00 5.9 ± 0.05 13.7 ± 0.00
15.625 6.0  ± 0.00 12.7 ± 0.00 5.1 ± 0.00 11.4 ± 0.70
31.25 6.0  ± 0.00 10.1 ± 0.00 5.0 ± 0.01 9.3 ± 0.00
62.5 5.9  ± 0.01 8.5 ± 0.00 5.0 ± 0.00 7.6 ± 0.00
125 5.4  ± 0.01 7.6 ± 0.00 4.6 ± 0.00 6.8 ± 0.00
250 5.0  ± 0.00 6.1 ± 0.00 4.1 ± 0.00 5.4 ± 0.00  
NP : Normal Pregnancy
Table 2 TNF-α levels (pg/mL) mean comparison before and after various concentrations 
of Phaleria macrocarpa’s extract treatment at 24 hours and 72 hours incubation 
time in preeclampsia HUVEC culture model.
Phaleria macrocar
pa’s extract concen
tration (μg/mL)
24 H INCUBATION TIME 72 H INCUBATION TIME
PE
 (Mean ± SD) P value*
PE 
(Mean ± SD) P value*
Control 18.7 ± 0.00 17.8 ± 0.03
0.977 18.3 ± 0.05 0.23 17.4 ± 0.00 1.00
1.953 17.9 ± 0.00 0.47 16.8 ± 0.01 0.36
3.906 15.3 ± 0.09 0.03 14.7 ± 0.31 1.00
7.813 14.5 ± 0.00 0.02 13.7 ± 0.00 0.18
15.625 12.8 ± 0.00 0.02 11.5 ± 0.71 1.00
31.25 10.1 ± 0.00 0.01 9.3 ± 0.00 0.08
62.5 8.6 ± 0.00 0.01 7.7 ± 0.00 0.07
125 7.6 ± 0.00 0.01 6.8 ± 0.00 0.07
250 6.1 ± 0.00 0.23 5.4 ± 0.00 0.06
* : statistically significant if p < 0.05
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Table 3 LC3-II levels (pg/mL) in preeclampsia and normal serum-induced HUVEC culture 
model treated with Phaleria macrocarpa’s extract in various concentrations 
incubated for 24 and 72 hours.
Phaleria macrocarpa’s 
extract 
concentration (μg/L)
24 H INCUBATION TIME 72 H INCUBATION TIME
NP* 
(Mean ± SD)
PE
 (Mean ± SD)
NP* 
(Mean ± SD)
PE 
(Mean ± SD)
Control 0.9 ± 0.00 6.5 ± 0.14 1.7 ± 0.07 6.3 ± 0.43
0.977 0.8 ± 0.02 6.3 ± 0.15 1.6 ± 0.02 6.0 ± 0.53
1.953 0.7 ± 0.00 6.0 ± 0.00 1.5 ± 0.00 6.3 ± 0.00
3.906 0.7 ± 0.00 5.9 ± 0.00 1.5 ± 0.00 5.9 ± 0.00
7.813 0.6 ± 0.00 5.8 ± 0.00 1.5 ± 0.00 5.9 ± 0.00
15.625 0.5 ± 0.01 5.4 ± 0.00 1.3 ± 0.00 5.5 ± 0.00
31.25 0.5 ± 0.00 3.9 ± 0.00 1.3 ± 0.00 4.0 ± 0.00
62.5 0.5 ± 0.00 2.3 ± 0.14 1.2 ± 0.01 2.4 ± 0.07
125 0.4 ± 0.00 2.1 ± 0.01 1.0 ± 0.01 2.1 ± 0.03
250 0.3 ± 0.00 1.2 ± 0.03 1.0 ± 0.00 1.3 ± 0.08
NP : Normal Pregnancy
Table 4 LC3-II levels (pg/mL) mean comparison before and after various concentrations of 
Phaleria macrocarpa’s extract treatment at 24 hours and 72 hours incubation time 
in preeclampsia HUVEC culture model
Phaleria macrocar
pa’s extract 
concentration (μg/mL)
24 H INCUBATION TIME 72 H INCUBATION TIME
PE 
(Mean ± SD) P value*
PE 
(Mean ± SD) P value*
Control 6.5 ± 0.14 6.3 ± 0.44
0.977 6.3 ± 0.15 0.27 6.0 ± 0.53 1.00
1.953 6.0 ± 0.00 1.00 6.3 ± 0.00 1.00
3.906 5.9 ± 0.00 1.00 5.9 ± 0.00 1.00
7.813 5.8 ± 0.00 1.00 5.9 ± 0.00 1.00
15.625 5.4 ± 0.00 1.00 5.5 ± 0.00 1.00
31.25 3.9 ± 0.00 1.00 4.0 ± 0.00 1.00
62.5 2.3 ± 0.14 1.00 2.4 ± 0.07 1.00
125 2.1 ± 0.01 0.73 2.1 ± 0.03 1.00
250 1.2 ± 0.03 0.42 1.3 ± 0.08 1.00
* : statistically significant if p < 0.05
123
Leo Simanjuntak: Phaleria macrocarpa’s Extract Inhibits Autophagy Probably
Table 1. shows TNF-α levels mean in 
difference preeclampsia and normal serum-
induced HUVEC culture model treated with 
Phaleria macrocarpa’s extract in various 
concentrations incubated for 24 and 72 hours.
Table 2 shows TNF-α level decreased in 
preeclampsia serum-induced HUVEC ATCC 
CRL 1730 following increased Phaleria 
macrocarpa’s extract concentration. TNF-α 
level significantly decreased after exposure 
of Phaleria macrocarpa’s extract on 
concentration 7.813 μg/mL. (p<0,05).
Table 3. shows LC3-II levels mean 
difference in preeclampsia and normal serum-
induced HUVEC culture model treated with 
Phaleria macrocarpa’s extract in various 
concentrations incubated for 24 and 72 hours.
Table 4 shows LC3-II level decreased 
in preeclampsia HUVEC model following 
increased Phaleria macrocarpa’s extract 
concentration. However, there was no 
significant decrease in mean LC3-II levels 
between control and PE model.
Figure 1. TNF-α levels in relation with Phaleria macrocarpa’s extract concentration
Figure 2. LC3-II levels in relation with Phaleria macrocarpa’s extract concentration
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Figure 1 shows that Phaleria 
macrocarpa’s extract at concentration of 62.5 
μg/mL reduce TNF-α level in preeclampsia 
model to normal pregnancy level.
Figure 2 shows that Phaleria 
macrocarpa’s extract at concentration more 
than 250 μg/mL needed to reduce LC3-
II level in preeclampsia model to normal 
pregnancy level.
Based on Pearson correlation test 
and Linear regression, TNF-α has a strong 
positive correlation with LC3-II (r = 0.958). The 
correlation between values indicates that 
when reduced TNF-α level, a proportional 
decrease in LC3-II levels also occurs, where 
a decrease in TNF-α level of 1 pg/mL will 
reduce LC3-II levels by 0.413 pg/mL.
Figure 3  Graph showing correlation between TNF-α and 
                  LC3-II levels 
Discussion
This were the first study to evaluate the effects 
of Phaleria macrocarpa (Scheff.) Boerl 
extract on Tumor Necrosis Factor – Alpha 
(TNF- α) and Protein Light Chain 3-II (LC3-
II) level in Preeclampsia-Induced Human 
Umbilical Vein Endothelial Cell (HUVEC). 
Preeclampsia and eclampsia have been known 
since ancient times but their pathophysiology 
is still not clearly understood. 
There is compelling evidence that 
endothelial dysfunction plays a role in 
the pathophysiology of preeclampsia. 
A consistent finding is the presence of 
glomerular endotheliosis in more than 70% 
of primiparous preeclampsia patients and this 
glomerular endotheliosis will disappear after 
delivery.
Oh et al.11 found that the administration 
of TNF-α in trophoblast cell line cultures 
causes an increase in expression of LC3-II. 
TNF-α is thought to stimulate autophagy 
through mechanisms that depend on ROS 
[16] thus it is believed that the autophagy 
process will be inhibited if oxidative stress 
and the inflammatory process are inhibited.
To date, invitro research using HUVEC 
has been done a lot recently. Previous 
invitro research on HUVEC cultures 
by treating with anti-inflammatory and 
antioxidant compounds such as curcumin 
and Papua ant nest (Myrmecodia pendens) 
decrease oxidative stress and inflammation 
characterized by decreased levels of MDA, 
and TNF-α. These studies conclude that 
the Papuan ant nests and curcumin have a 
therapeutic effect on preeclampsia.22-23
TNF-α is considered as one of the 
potentially specific markers for preeclampsia 
and contributes to the formation of free 
radicals such as peroxides (H2O2), and 
superoxide (O2).
6 Autophagy can be 
induced by many overlapping factors such 
as nutritional deficiencies, growth factors 
deficiencies, and intracellular stress due to 
hypoxia. LC3-II is used as a typical marker 
of autophagosome formation in autophagy.
In this study results showed TNF-α 
levels in preeclampsia HUVEC culture model 
was higher than normal pregnancy HUVEC 
culture model. TNF-α level decreased in 
preeclampsia and normal serum-induced 
HUVEC ATCC CRL 1730 culture following 
increased Phaleria macrocarpa’s extract 
concentration. TNF-α level significantly 
decreased after exposure of Phaleria 
macrocarpa’s extract on concentration 7.813 
μg/mL. Phaleria macrocarpa’s extract at 
concentration of 62.5 μg/mL reduce TNF-α 
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level to normal level.
This study shows LC3-II levels mean 
difference in preeclampsia and normal 
serum-induced HUVEC culture model 
treated with Phaleria macrocarpa’s extract 
in various concentrations incubated for 24 
and 72 hours. LC3-II level decreased in 
preeclampsia and normal serum-induced 
HUVEC ATCC CRL 1730 culture following 
increased Phaleria macrocarpa’s extract 
concentration. However, there was no 
significant decrease in mean LC3-II levels 
between control and PE model treated with 
Phaleria macrocarpa’s extract in various 
concentrations incubated for 24 and 72 
hours and Phaleria macrocarpa’s extract at 
concentration more than 250 μg/mL needed 
to reduce LC3-II level in preeclampsia model 
to normal pregnancy level.
TNF-α has a strong positive correlation 
with LC3-II (r=0.958). The correlation 
between values indicates that when reduced 
TNF-α level, a proportional decrease in LC3-
II levels also occurs, where a decrease in 
TNF-α level of 1 pg/mL will reduce LC3-II 
levels by 0.413 pg/mL.
Although there are many studies about 
Phaleria macrocarpa, one potential limitation 
in this study is the lack of prior research 
studies about the toxic profile or side effects 
of Phaleria macrocarpa’s extract specifically 
when used in an in-vivo model. We selected 
HUVEC culture, as endothelial dysfunction 
mainly happened in endothelial cells. This 
limitation encourages further clinical trials as 
the biologically active Phaleria macrocarpa’s 
extract compound can be further used for 
preeclampsia treatment and prevention.
The result of present study suggests that 
Phaleria macrocarpa’s extract contains anti-
inflammatory activity proven by decreased 
level of TNF-α. It was also described that 
TNF-α level decreased in preeclampsia 
and normal serum-induced HUVEC ATCC 
CRL 1730 following increased Phaleria 
macrocarpa’s extract concentration. Thus, 
Phaleria macrocarpa’s extract might be used 
as agent to restore endothelial dysfunction 
in preeclampsia. Since the decreased the 
level of TNF-α in preeclampsia-induced 
HUVEC ATCC CRL 1730 culture, further 
clinical studies regarding the use of Phaleria 
macrocarpa’s extract in treatment are 
encouraged.                          
Conclusion
The Phaleria macrocarpa’s extract reduce 
TNF-α level siginificantly at concentration 
of 7.813 μg/mL in preeclampsia-induced 
HUVEC ATCC CRL 1730 culture. Phaleria 
macrocarpa’s extract at concentration of 62.5 
μg/mL reduce TNF-α level to normal level. 
There was no significant decrease in mean 
LC3-II levels between control and PE model 
treated with Phaleria macrocarpa’s extract 
in various concentrations incubated for 24 
and 72 hours and Phaleria macrocarpa’s 
extract at concentration more than 250 μg/mL 
needed to reduce LC3-II level in preeclampsia 
model to normal pregnancy level. TNF-α has 
a strong positive correlation with LC3-II, 
reduced TNF-α level will decrease LC3-II 
levels, where a decrease in TNF-α level of 1 
pg/mL will reduce LC3-II levels by 0.413 pg/
mL.
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